DIAbetes Maximal ACCeleration

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 238 participants.

Also called NCT05646147

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 238 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05646147
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05646147. Allocation not applicable; no masking; primary purpose diagnostic. Start 2023-07 (anticipated); primary completion 2025-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
DIAbetes Maximal ACCeleration
Acronym
DIAMACC
Condition
Peripheral Arterial Disease
Condition
Diagnosis
Condition
Diabetic Foot
Intervention (Device)
Maximal Systolic Acceleration
Lead sponsor
Leiden University Medical Center (class: other)

Record details

Record id
cardio:ct-nct05646147
Content hash
fd090ea13fbb59b836b43f7000a233d4cbe256ac8c83f14c92b37d4bd8c6f490